Improved alcohol and drug care for women at family planning clinics
Improving alcohol and substance use care access and outcomes during the reproductive years: A Type 1 Hybrid Trial in Family Planning Clinics
This project brings screening, brief counseling, and referrals for alcohol and drug use into family planning clinics for women of reproductive age and compares ways to deliver that care, including telemedicine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11184514 on NIH RePORTER |
What this research studies
If you go to a participating family planning clinic, clinic staff will offer routine screening and short counseling for alcohol and drug use and can connect you with treatment when needed. The study tests an implementation strategy (Implementation and Sustainment Facilitation, ISF) to help clinics adopt and keep using these services across a large national women's health network. Researchers will combine clinic rollout data, patient surveys, and interviews to learn what helps clinics deliver this care and what helps patients follow up. Some of the care and follow-up may be offered by telemedicine to make services easier to access.
Who could benefit from this research
Good fit: Women of reproductive age who attend participating family planning or women's health clinics and who report risky alcohol or drug use are the ideal candidates.
Not a fit: People who do not attend the participating clinics, who need immediate inpatient detox or specialized addiction services, or whose care is outside the clinic network may not directly benefit from this project.
Why it matters
Potential benefit: If successful, this could make it easier for women to get brief help and timely referrals for risky alcohol or drug use during routine reproductive health visits.
How similar studies have performed: Screening, brief intervention, and referral to treatment (SBIRT) has shown benefit in primary care and mental health settings, but its use in women's health clinics and via telemedicine is much less tested.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Welsh, Justine Wittenauer — Emory University
- Study coordinator: Welsh, Justine Wittenauer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.